Boston-based a2z Radiology raised $4.5M and earned FDA clearance for its Unified Triage AI solution for abdominal and pelvic CT scans.
Key Details
- 1a2z Radiology, founded in 2024, is developing AI tools for medical imaging interpretation.
- 2The company secured $4.5 million in seed funding from investors including SeaX and Khosla Ventures.
- 3Its Unified Triage system received FDA clearance and is designed as a multi-condition tool for abdomen-pelvis CT analysis.
- 4a2z claims its product is the first of its kind, focusing on broad multi-condition triage instead of single findings.
- 5The funds will be used to commercially deploy Unified Triage and develop further imaging AI products.
- 6Harvard biomedical informatics professor Pranav Rajpurkar co-founded the startup.
Why It Matters
Multi-condition AI tools could streamline radiology workflows, helping to detect a broader range of pathologies in a single scan and supporting radiologist efficiency. Regulatory milestones and investment indicate escalating momentum for generalist AI in medical imaging.
Source
Radiology Business
Related News
•AuntMinnie
GPT-4o AI Matches Radiologists in Follow-Up Imaging Recommendations
GPT-4o matched the performance of experienced radiologists and surpassed residents in recommending follow-up imaging from routine radiology reports.
•Cardiovascular Business
AI Leverages Head CTs for Automated Heart Risk Assessments
AI models can turn routine head CT scans into automated cardiovascular risk assessments, expanding the utility of radiology studies.
•Radiology Business
MRI AI for Parkinsonian Syndrome Gains FDA De Novo Clearance
Neuropacs Corp.'s MRI AI software earns FDA De Novo classification to assist in Parkinsonian syndrome diagnosis.